These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 24811944)

  • 1. Successful desensitization in patient with type 2 diabetes with an insulin allergy using insulin pump and glargine.
    Petrovski G; Zivkovic M; Milenkovic T; Ahmeti I; Bitovska I
    Acta Diabetol; 2014 Dec; 51(6):1073-5. PubMed ID: 24811944
    [No Abstract]   [Full Text] [Related]  

  • 2. Desensitization of allergy to human insulin and its analogs by administering insulin aspart and insulin glargine.
    Wu P; Ji C; Wang M; Zou S; Ge W
    Ann Endocrinol (Paris); 2013 Feb; 74(1):56-8. PubMed ID: 23351561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful desensitization by glargine administration in a patient with insulin allergy: a case report.
    Hara M; Izumida Y; Sato N; Ohashi K; Osuga J; Tobe K; Tsukamoto K; Kadowaki T
    Diabetes Res Clin Pract; 2009 Jun; 84(3):e48-9. PubMed ID: 19286270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desensitization for insulin allergy: a useful treatment also for local forms.
    Eguíluz-Gracia I; Rodríguez-Alvarez M; Cimarra-Alvarez M; Sanabria-Pérez MC; Martínez-Cócera C
    J Investig Allergol Clin Immunol; 2012; 22(3):215-6. PubMed ID: 22697012
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe insulin allergy successfully treated with continuous subcutaneous insulin infusion.
    Fujikawa T; Imbe H; Date M; Go Y; Kitaoka H
    Diabetes Res Clin Pract; 2012 Aug; 97(2):e31-3. PubMed ID: 22609054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Insulin allergy whose local/systemic reactions were reduced by desensitization with long-acting insulin analog, glargine].
    Tuboi M; Tsuchiya T; Taguchi R; Tanaka Y; Iwasaki Y; Hashimoto K; Kakizaki S; Okada S; Shimizu H; Mori M
    Nihon Naika Gakkai Zasshi; 2010 Jan; 99(1):133-5. PubMed ID: 20196485
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin desensitization with insulin lispro and an insulin pump in a 5-year-old child.
    Eapen SS; Connor EL; Gern JE
    Ann Allergy Asthma Immunol; 2000 Nov; 85(5):395-7. PubMed ID: 11101184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin glulisine in the treatment of allergy to rapid acting insulin and its rapid acting analogs.
    Mollar-Puchades MA; Villanueva IL
    Diabetes Res Clin Pract; 2009 Jan; 83(1):e21-2. PubMed ID: 19070911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful Treatment of Insulin Allergy with Desensitization Therapy: A Case Report and Literature Review.
    Elfekih H; Hadjkacem F; Elleuch M; Ghorbel D; Charfi N; Mnif F; Rekik N; Mnif M; Abid M
    Iran J Allergy Asthma Immunol; 2019 Oct; 18(5):572-583. PubMed ID: 32245301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sustained specific desensitization in a patient with diabetes mellitus with insulin allergy under conditions of immunoglobulin control].
    Dreval' AV; Mutina ES; Iuldashev AK; Serova TI; Sitnikova ND
    Probl Endokrinol (Mosk); 1978; 24(4):51-4. PubMed ID: 683971
    [No Abstract]   [Full Text] [Related]  

  • 11. [Insulin allergy in type II diabetes: rapid desensitization].
    Ruíz Barrera E; Martínez-Cario Cueto S
    Rev Alerg Mex; 1994; 41(1):19-24. PubMed ID: 8087231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin allergy and insulin resistance.
    Goldfine AB; Kahn CR
    Curr Ther Endocrinol Metab; 1994; 5():461-4. PubMed ID: 7704774
    [No Abstract]   [Full Text] [Related]  

  • 13. Allergy to human insulin and specific immunotherapy with glargine; case report with review of literature.
    Hasani-Ranjbar S; Fazlollahi MR; Mehri A; Larijani B
    Acta Diabetol; 2012 Feb; 49(1):69-73. PubMed ID: 21279523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous subcutaneous insulin infusion allows tolerance induction and diabetes treatment in a type 1 diabetic child with insulin allergy.
    Hasselmann C; Pecquet C; Bismuth E; Raverdy C; Sola-Gazagnes A; Lobut JB; Carel JC; Tubiana-Rufi N
    Diabetes Metab; 2013 Apr; 39(2):174-7. PubMed ID: 23206896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I allergy to insulin: case report and review of localized and systemic reactions to insulin.
    Hoffman AG; Schram SE; Ercan-Fang NG; Warshaw EM
    Dermatitis; 2008; 19(1):52-8. PubMed ID: 18346398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia.
    Hsia E; Seggelke S; Gibbs J; Hawkins RM; Cohlmia E; Rasouli N; Wang C; Kam I; Draznin B
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3132-7. PubMed ID: 22685233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A practical, clinical approach to the assessment and management of suspected insulin allergy.
    Jacquier J; Chik CL; Senior PA
    Diabet Med; 2013 Aug; 30(8):977-85. PubMed ID: 23601039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anaphylactic shock due to recombinant human insulin: follow-up of a desensitization protocol by basophil activation test].
    Luyasu S; Hougardy N; Hasdenteufel F; Jacquenet S; Weber E; Moneret-Vautrin A; Kanny G
    Rev Med Interne; 2011 Jan; 32(1):39-42. PubMed ID: 21106278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observational study of kidney function and albuminuria in patients with type 2 diabetes treated with exenatide BID versus insulin glargine.
    Pawaskar M; Tuttle KR; Li Q; Best JH; Anderson PW
    Ann Pharmacother; 2014 May; 48(5):571-6. PubMed ID: 24497624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged desensitization required for treatment of generalized allergy to human insulin.
    Thompson DM; Ronco JJ
    Diabetes Care; 1993 Jun; 16(6):957-8. PubMed ID: 8325221
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.